Enlivex Ltd. (ENLV)
0.6726
-0.02
(-2.89%)
USD |
NASDAQ |
Jun 10, 16:00
0.67
0.00 (0.00%)
After-Hours: 06:23
Enlivex 1 Year Total Returns (Daily) : -29.94% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -29.94% |
| June 09, 2026 | -26.32% |
| June 08, 2026 | -26.17% |
| June 05, 2026 | -22.83% |
| June 04, 2026 | -15.00% |
| June 03, 2026 | -9.60% |
| June 02, 2026 | -9.59% |
| June 01, 2026 | -7.76% |
| May 29, 2026 | -13.58% |
| May 28, 2026 | -19.54% |
| May 27, 2026 | -21.41% |
| May 26, 2026 | -29.85% |
| May 22, 2026 | -25.42% |
| May 21, 2026 | -26.47% |
| May 20, 2026 | -28.94% |
| May 19, 2026 | -28.84% |
| May 18, 2026 | -30.27% |
| May 15, 2026 | -30.04% |
| May 14, 2026 | -28.91% |
| May 13, 2026 | -26.76% |
| May 12, 2026 | -25.29% |
| May 11, 2026 | -27.14% |
| May 08, 2026 | -25.96% |
| May 07, 2026 | -23.51% |
| May 06, 2026 | -24.27% |
| Date | Value |
|---|---|
| May 05, 2026 | -21.17% |
| May 04, 2026 | -18.06% |
| May 01, 2026 | -22.29% |
| April 30, 2026 | -19.63% |
| April 29, 2026 | -23.35% |
| April 28, 2026 | -19.81% |
| April 27, 2026 | -10.38% |
| April 24, 2026 | -7.45% |
| April 23, 2026 | -1.45% |
| April 22, 2026 | -0.16% |
| April 21, 2026 | -0.17% |
| April 20, 2026 | 1.85% |
| April 17, 2026 | -0.06% |
| April 16, 2026 | 3.33% |
| April 15, 2026 | -8.02% |
| April 14, 2026 | -7.92% |
| April 13, 2026 | -6.61% |
| April 10, 2026 | 4.51% |
| April 09, 2026 | 3.22% |
| April 08, 2026 | 2.54% |
| April 07, 2026 | -6.36% |
| April 06, 2026 | -1.62% |
| April 02, 2026 | -5.74% |
| April 01, 2026 | 1.29% |
| March 31, 2026 | -4.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -65.52% |
| Brainstorm Cell Therapeutics, Inc. | -79.05% |
| Summit Therapeutics, Inc. | -40.90% |
| PeptiDream Inc. | -55.80% |
| Kezar Life Sciences, Inc. | 55.77% |